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KIRSCHBAUM and Bittner (1945) considered squamous metaplasia as a
characteristic change, specific to chemically-induced breast cancer, and pointed
out that the different histological appearance of methylcholanthrene-induced
and spontaneous breast tumours may be the expression of a different origin
of these two types of breast cancer. They found, however, a higher incidence
and an earlier appearance of methylcholanthrene-induced breast cancer in mice
of a strain known to possess the mammary tumour agent (milk factor) than in
mice of the same strain deprived of it. This observation suggested a relation-
ship between spontaneous and induced manmmary tumours, namely, that the
mammary tumour agent may take part in the origin of both types of tumours.
Although their observations indicated a certain strain specificity to the develop-
ment of methylcholanthrene-induced mammary tumours, the relationship
between susceptibility to the development of spontaneous and methylchol-
anthrene-induced breast cancer remained uncertain. In another series of
experiments, Kirschbaum, Williams and Bittner (1946) came to the conclusion
that the histogenesis of breast tumours induced with methylcholanthrene is
the same either in the presence or in the absence of the mammary tunaour agent
and differs from that of spontaneous breast cancer in mice of the same strain.
In spite of the previously observed difference between the incidence of methyl-
cholanthrene-induced breast cancer in mice with the mammary tumour agent
and in mice of the same strain deprived of the agent, Kirschbaum, Williams and
Bittner (1946) were inclined to postulate a different aetiology for spontaneous
and induced breast cancer because of the observed differences in the histogenesis
of these two types of tumours. Strong (1945) considered that the action of
methylcholanthrene may either involve a reversal of genetic resistance to the
development of breast tumours or lead to the manifestation of a new type of
susceptibility different from that involved in spontaneous breast tumours.
Thus it was not clear whether the origin of breast tumours induced by methyl-
cholanthrene was the same as or different from that of spontaneous mammary
cancer, and the part played by the mammary tumour agent in the development
of chemically-induced tumours required clarification. The possibility that the
action of methylcholanthrene may result in the appearance of the mammary
tumour agent in mnice of strains known to lack the agent also required investi-
gation.
In connection with the work quoted and the results described in a previous
paper (Dmochowski and Orr, 1949) experiments were carried out in order to find
out if the milk factor plays a part in the development of mammary tumours
induced with methylcholanthrene.CHEMICALLY INDUCED BREAST TUMOURS
MATERIAL AND METHODS.
Breast tumours of C3H high- and C57 low-breast-cancer strain male mice
induced by combined application of oestrone and methylcholanthrene, of C3H
males following treatment with oestrone, and of C57 females after treatment
with methylcholanthrene were investigated for the presence of the mammary
tumour agent. In addition, breast tumours induced in IF low-breast-cancer
strain mice with methylcholanthrene (Orr, 1946) were also examined.
Breast tumour tissue desiccated and stored for periods of time varying from
1 week to 7 months was used. The tumour tissue, immediately before use,
was resuspended in distilled water in a proportion of 1:10 and injected sub-
cutaneously every other day into 4-6 weeks old susceptible C57 x RIII hybrid
female mice. All females were forcibly bred by removing the first three litters
and then allowed to breed in a normal way.
EXPERIMENTAL PROCEDURE AND RESULTS.
Experiment 1.
Four breast tumours induced in IF low-breast-cancer strain females with
methylcholanthrene and one breast tumour induced in a C3H male with oestrone
and methylcholanthrene were tested for the presence of the mammary tumour
agent.
Thirty-six C57 x RIII hybrid females which were litter mates were divided
into 5 groups.
The first group of C57 x RIII hybrid females received 5 injections, each of
0.5 c.c. (0.05 g. fresh tissue) of a distilled water suspension of dried IF tumour
No. 36.23, giving a total equivalent to 0.25 g. offresh tissue.
The second and third groups of C57 x RIII females were given 7 similar
injections of IF tumours Nos. 35.94 and 37.39 respectively, corresponding to
0.35 g. offresh tissue in each case.
Thefourth group ofmice, 12 females in all, received 12 subcutaneous injections
of IF tumour No. 34.63, a total of 0.6 g. of fresh tissue.
The fifth group of mice was given 8 subcutaneous injections of 0-5 c.c.
distilled water suspension ofC3H No. 30 breast tumour induced in a male mouse
with combined treatment of oestrone and methylcholanthrene (Dmochowski
and Orr, 1949) comprising a total of 0-4 g. offresh tumour tissue.
As can be seen from Table I, no breast tumours developed in any of the
C57 x RIII susceptible hybrid mice given repeated injections of distilled water
suspensions of dried breast tumours induced in IF low-breast-cancer strain mice
with methylcholanthrene. During this time 4 out of 6 C57 x RIII hybrids,
given breast tumour tissue induced in a C3H high-breast-cancer strain male
mouse with oestrone and methylcholanthrene, developed breast tumours. All
tumours were examined microscopically and were found to be adenocarcinomata.
It can be concluded that the mammary tumour agent is present in tumours
induced in C3H strain males by combined application of oestrone and methyl-
cholanthrene. Tumours induced in IF low-breast-cancer strain female mice do
not seem to harbour the agent.
Experiment 2.
Six mammary tumours, 2 induced in C33H strain males by painting with
oestrone, 2 which developed in C3H strain males after treatment with oestrone
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and methylcholanthrene, one induced in a 057 strain breeding female with
methylcholanthrene and one in a C57 strain male with oestrone and methyl-
cholanthrene (Dmochowski and Orr, 1949) were tested for the presence of the
mammary tumour agent.
Altogether 36 C57 x RIII hybrid females were employed in the experiment,
and 6 mice were used for each of the tested tumours.
Mice of the first group were given C3H male No. 25 breast tumour tissue
and mice of the second group C3H male No. 27 breast tumour tissue, both
induced by administration of oestrone and methylcholanthrene. Each of the
two groups received 6 injections, each of 1 c.c. of a distilled water suspension
of dried tumour tissue, giving a total amount equal to 0.6 g. of fresh tissue.
Mice ofthe third group received 6 injections, each of 1 c.c. ofa distilled water
suspension of C3H No. 41 male tumour tissue induced with oestrone, corres-
ponding to a total of 0.6 g. offresh tissue.
Mice of the fourth group received 4 injections of C3H No. 38 tumour tissue
induced in a male mouse with oestrone, giving an amount of dried tissue equal
to 0.4 g. of fresh tumour tissue.
Breast tumour tissue induced in C57 maleNo. 23 by administration ofoestrone
and methylcholanthrene was given to mice of the fifth group in 3 injections,
.comprising a total of 0.3 g. offresh tissue.
Mice ofthe sixth group were given 6 injections, each of 1.0 c.c. of a distilled
water suspension of breast tumour induced in a C57 No. 4 breeding female with
methylcholanthrene, an amount equal to 0-6 g. of fresh tissue.
The amount of tumour tissue administered in a given case necessarily varied
with the size ofthe original tumour.
As can be seen from Table II, none of the C57 x RIII hybrid females, given
repeated injections of breast tumour tissue induced in C57 low-breast-cancer
strain mice either with oestrone and methylcholanthrene or with methylchol-
anthrene alone, developed breast cancer. The C57 x RIII hybrid female mice
injected with C3H breast tumour tissue induced by oestrone and methylchol-
anthrene developed tumours; breast tumours were also induced in C57 x RIII
hybrid females with C3H breast tumour tissue obtained after administration of
oestrone alone. The results of the present experiment taken in conjunction
with the results obtained from Experiment 1 show that the mammary tumour
agent is present in breast tumours induced in C3H high-breast-cancer strain
male mice either by oestrogenic hormones alone, or by a combined treatment
with methylcholanthrene and oestrogens. Mammary tumours induced in IF
and C57 low-breast-cancer strain females after administration of methylchol-
anthrene as well as tumours obtained in C57 strain males after application of
oestrone and methylcholanthrene do not seem to possess the agent.
DISCUSSION.
Biological tests for the presence of the mammary tumour agent in breast
cancer induced in high- and low-breast-cancer strain mice by administration
of methylcholanthrene alone, oestrone alone, or combined treatment have
revealed a difference between induced breast tumours according to the strain
in which they originated.
The mammary tumour agent is present in breast tumours induced in C3H
high-breast-cancer strain males following treatment with oestrogenic hormones
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and also after combined administration of these hormones and methylchol-
anthrene. This appears to be the first recorded demonstration of the mammary
tumour agent in breast tumours of male mice from a high-breast-cancer strain.
It was to be expected that male mice of C3H strain, whose females are very
susceptible to the development of breast cancer, possess the agent, and indeed
recent experiments (Andervont and Dunn, 1948) have shown the presence of
the agent in the seminal vesicles of C3H males.
The results of the tests for the presence of the agent in breast tumours of
C57 black low-breast-cancer strain male and female mice taken together with
those of the tests of mammary tumours of IF low-breast-cancer strain females
obtained after methylcholanthrene treatment, give a fair indication that breast
cancer induced with methylcholanthrene in low-breast-cancer strain mice, both
males and females, does not possess the mammary tumour agent. The method
of repeated injections (Dmochowski, 1945) is very effective, and should have
revealed the presence even of small amounts of the agent. Methylcholanthrene,
therefore, does not induce the appearance of the milk factor in mice which do
not possess it before treatment.
It is known from the experiments carried out by various workers that certain
strains of mice show a greater susceptibility to the induction of breast cancer
with methylcholanthrene than other strains. Kirschbaum and Bittner (1945),
found that dba high-breast-cancer strain is very susceptible, while the C3H
high-breast-cancer strain is less susceptible to the development of breast cancer
following treatment with methylcholanthrene. Similar differences in the
susceptibility to carcinogen-induced breast cancer may also be found in low-
breast-cancer strains. Strain NH (Kirschbaum, Williams and Bittner, 1946)
and also strain NHO (Strong, 1945) are susceptible, C57 black strain used by
Kirschbaum, Williams and Bittner (1946) is not susceptible under the conditions
of administration of methylcholanthrene employed by these workers. The
sub-line of C57 black low-breast-cancer strain maintained in this department
is susceptible, but to a less degree than IF low-breast-cancer strain mice, to the
induction of breast cancer following the application of methylcholanthrene by
the present method. Our C57 black strain mice do not develop breast cancer
when given material containing the mammary tumour agent at the age of 4-6
weeks, even after large quantities of the material and in spite of increased hor-
monal stimulation (repeated pregnancies). This indicates that mature mice
of this strain, though resistant to the mammary tumour agent, are susceptible
to a different agent, namely, methylcholanthrene.
The development of breast tumours in both high- and low-breast-cancer
strain mice after treatment with methylcholanthrene, the differences in the
susceptibility to the development of these tumours between various strains
which possess the agent as well as between strains which lack the agent, the
absence of the agent in induced breast tumours of low-breast-cancer strain mice,
although such tumours are similar in microscopical appearance to induced breast
tumours of high-breast-cancer strain mice, support the conclusion that the
action of methylcholanthrene in the induction of breast cancer is independent
of the milk factor.
The results of the tests for the presence of the mammary tumour agent in
breast tumours induced in low-cancer strain mice seem to support the conclusion
that the type of susceptibility operative in the development of methylcholan-
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threne-induced breast tumours differs from that involved in the origin of
spontaneous breast cancer. The susceptibility to spontaneous breast cancer may
be different from the susceptibility to chemically-induced breast cancer because
mice which show low susceptibility to the mammary tumour agent may show a
high susceptibility to methylcholanthrene, and vice versa.
The results of our tests for the presence of the milk factor in methylchol-
anthrene-induced breast tumours in low-breast-cancer strain miice show that
methylcholanthrene does not induce the appearance of the factor in mice of
strains which are known to lack it.
SUMMARY.
The present experiments have shown the mammary tumour agent to be
present in breast tumours induced in C3H high-breast-cancer strain males,
following application of methylcholanthrene and oestrogen, or oestrogen alone.
Biological tests have not revealed the agent in breast cancer induced in C57
black low-breast-cancer strain males, after the application of oestrogen and
methylcholanthrene. Breast tumours induced in C57 black and IF low-breast-
cancer strain females by methylcholanthrene do not contain the mammary
tumour agent.
The part played by the carcinogenic hydrocarbons in the induction of breast
cancer in mice is discussed.
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AFTER the discovery of the mammary tumour agent or the milk factor in
the milk of high-breast-cancer strain female mice (Bittner, 1936), numerous
investigations were undertaken in order to ascertain its presence in various
tissues and organs of normal mice of high-breast-cancer strains, and also in
spontaneous breast tumours of these mice. For this purpose either implantation
of various organs into suitable susceptible test mice was used, or extracts of
these organs and tissues were made and injected into the test mice. In this
way, on the basis of the development of breast cancer in the test mice, the milk
factor was found to be present in the spleen (Bittner, 1939a; Andervont,